In the specialized field of biochemical research, the CH-275 peptide has garnered significant attention as a highly specific tool for studying cellular signaling pathways. As someone deeply interested in the nuances of peptide chemistry and receptor interaction, Introduction to Proteasomal SplicedPeptides. Initial discovery of antigenicpeptidesrecognized by CTL and produced bypeptidesplicing in the proteasome.Read more I have spent considerable time reviewing the literature regarding this somatostatin analog. My focus here is to provide a comprehensive overview of wh CH 275 (acetate) at makes this compound unique in laboratory settings, strictly for informational purposes regarding its role in academic and biochemical inquiry.
Understanding the Nature of CH-275
At its core, CH 275 is a peptide analog of somatostatin, designed with high structural precision. It is widely recognized in scientific literature as a cyclic peptide agonist of somatostatin receptor 1 (SST1). Unlike broader analogs that might interact with multiple receptor subtypes, CH-275 is prized for its selectivity.
When conducting resear by TJ Wang·2004·Cited by 2071—The natriureticpeptidesare counterregulatory hormones involved in volume homeostasis and cardiovascular remodeling. The prognostic significance of plasma ch, purity is paramount. CH 275 is a high-purity biochemical reagent often sourced by laboratories to ensure that experimental results—such as those involving signaling pathways—remain consistent and reproducible. The compound, identified by CAS number 174688-78-9, is frequently utilized in studies that require a potent and selective interaction with the SST1 receptor, often exhibiting a Ki of approximately 52 nM.
Technical Specifications and Receptor Selectivity
The utility of this peptide lies in its selective behavior. In various displacement experiments, it has demonstrated a clear preference for SST1 over other receptors like SST2, SST3, and SST4. This selectivity is a critical factor for researchers aiming to isolate the physiological effects mediated specifically through the SST1 receptor.
In terms of peptide synthesis, the complexity of creating cyclic structures like CH-275 requires advanced methodologies. The synthesis must account for the stability of the cyclic backbone to maintain its biological activity. Furthermore, researchers have explored CH-275 peptide derivatives, su The conjugate may be used to treat an infection such as a bacterial infection (e.g., any known in the art). Antimicrobialpeptidesinclude (KIAGKIA) 3peptide, Read more ch as those conjugated with chelating agents like DTPA, to expand the potential applications of this molecule in targeted imaging or other specialized biochemical assays.
Broader Context in Peptide Research
The study of peptides is a vast CH 275 | cyclic peptide agonist | somatostatin receptor 1 field, encompassing everything from simple chains to complex, macrocyclic structures. While CH-275 is a specialized tool, it sits within a broader framework of research involving:
* Signaling Pathway Modulation: Beyond its primary role, researchers have investigated how specialized molecules can prevent adrenergic regulation of pacemaker channels, providing insights into complex cellular feedback loops.
* Structural Diversity: Whether discussing a peptide-based biostimulant used in agricultural science or a highly specific reagent like CH-275, the underlying chemistry of amino acid sequencing remains the foundation of discovery.
* Analytical Methods: As detailed in many a chapter on proteomics, the characterization of such molecules requires rigorous analytical techniques to verify higher-order structures and purity levels.
Observations on Laboratory Use
For those involved in laboratory work, the distinction between different analogs is vital. When comparing CH-275 to other somatostatin analogs, the primary differentiator is its specific affinity. Whether one is investigating the channel dynamics of a cell or the regulatory effects on adenylyl cyclase, the use of a well-characterized agonist is indispensable.
It is fascinating to see how the evolution of peptides continues to influence our understanding of molecular biology. From the initial synthesis to the final app by JP Hannon·2002·Cited by 138—Short cyclic or linearpeptideanalogs show selectivity for sst2/sst5 (octreotide, lanreotide, BIM 23027), sst1 (CH-275), sst3 (sst3-ODN-8), or sst5 Read more lication in a controlled environment, every step—including the careful handling of CH-275—is a testament to the precision required in modern biochemical research.
***
*Disclaimer: This article is for educational and informational purposes only. The s by A Saponaro·2018·Cited by 63—Cell-penetrating peptide drugsprevent adrenergic regulation of pacemaker channelswithout altering the overall response of the cell to ubstances mentioned are for laboratory research use only and a Ligand list re not intended for human consumption, medical diagnosis, or prescription use.*